Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntertek Group Regulatory News (ITRK)

Share Price Information for Intertek Group (ITRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,944.00
Bid: 4,934.00
Ask: 4,938.00
Change: 8.00 (0.16%)
Spread: 4.00 (0.081%)
Open: 4,934.00
High: 4,960.00
Low: 4,914.00
Prev. Close: 4,936.00
ITRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

19 May 2011 07:00

RNS Number : 8786G
Intertek Group PLC
19 May 2011
 



Interim Management Statement

 

Intertek Group plc ("Intertek"), a leading provider of quality and safety services to a wide range of industries around the world, today releases its Interim Management Statement for the period from 1 January 2011.

 

At constant exchange rates, organic revenue for the first four months of the year ("the period") increased by 8% over the corresponding period in 2010. After taking into account revenue from acquisitions made in 2010, partially offset by an unfavourable currency effect, total reported revenue increased by 11% in the same period.

 

Overall, the Group continued to benefit from improving conditions in many of its markets.

 

The Commodities division had good revenue growth. Demand for petroleum related cargo inspections and non-inspection related testing in North America increased slightly as clients' trading, refining and fuel development activities expanded compared to the prior year period. Minerals and Government Services had a strong start to the year with high global demand for minerals driving exploration and mining activity and Government Services benefiting from higher imports into Intertek's client countries.

 

The Commercial & Electrical division also experienced good revenue growth. Innovation in renewable energy technologies and energy storage devices continued to generate increased demand, along with the desire of clients in a variety of industries to reduce the energy usage and environmental impact of their products.

 

In this seasonally slower period, Consumer Goods organic revenue growth was lower than expected mainly as a result of an unusually long new year holiday shut-down period in China. The drive by global retailers to source goods where production costs are lowest continues and Consumer Goods is responding to this ongoing trend.

 

Industry Services, within the Industry & Assurance division, grew revenue well and has a pipeline of new contract opportunities with demand in both emerging and developed markets where global and local clients are seeking support with infrastructure projects. Systems Certification had a solid start to the year, and this is expected to improve further as new contracts commence. The recently announced Moody acquisition will add considerably to the scale of this division and support its growth profile.

 

Demand for chemicals and materials analysis in support of European and North American clients' new product development continued to drive revenue growth in the Chemicals & Pharma division.

 

Whilst the Group's activities in Japan and North Africa are modest, the Group has experienced an element of disruption to its activities.

 

Operating profit increased in the period mainly due to the total reported revenue growth of 11% but on a slightly lower group profit margin compared to the same period last year. Positive margin development in Commodities and Commercial & Electrical was offset by a lower margin and slower growth in the Consumer Goods division.

 

Intertek's operations are conducted in over 100 countries and 75 different currencies. Approximately three quarters of Intertek's full year reported operating profit is derived from US dollars or currencies linked to the US dollar. The Group's financial results continue to reflect the impact of translating local financial results into sterling. For the year ended 31 December 2010, the average US$ / £ translation rate was $1.55 and for the first four months of 2011 the average rate was $1.60.

 

The acquisition of Moody International Inc ("Moody"), as announced on 7 March, was completed on 27 April. This was funded from existing and new debt facilities. Following the acquisition the Group's Net Debt to EBITDA ratio increased to a comfortable level of 1.9 times on a pro-forma basis.

 

Wolfhart Hauser, Chief Executive Officer, said:

 

"All of our divisions had positive revenue growth in the first four months of the year, with higher than expected performances in the Commodities and Commercial & Electrical divisions offsetting the slower start for Consumer Goods.

 

"We are pleased to have closed the Moody acquisition ahead of schedule, and integration is proceeding smoothly, including a number of joint contract bids having already been submitted to clients. The business has developed well over the first four months of the year in line with expectations.

 

"Looking ahead, we expect to achieve Group organic revenue growth, at constant exchange rates, in the high single digits range for the full year." 

 

The Annual General Meeting of Intertek will be held tomorrow, 20 May 2011, at 1.00pm at The Westbury Hotel, Conduit Street, London, W1S 2YF. The Group's half year results to 30 June 2011 will be announced on Monday 1 August 2011.

 

Contacts

Aston Swift / Sarah Ogilvie

Telephone: +44 (0) 20 7396 3400

aston.swift@intertek.com / sarah.ogilvie@intertek.com

 

Richard Mountain, Financial Dynamics

Telephone: +44 (0) 20 7269 7291

richard.mountain@fd.com

 

Notes to Editors

 

ABOUT INTERTEK

 

Intertek is a leading provider of quality and safety solutions serving a wide range of industries around the world. From auditing and inspection, to testing, quality assurance and certification, Intertek people are dedicated to adding value to customers' products and processes, supporting their success in the global marketplace. Intertek has the expertise, resources and global reach to support its customers through its network of more than 1,000 laboratories and offices and 30,000 people in over 100 countries around the world. Intertek Group plc (LSE: ITRK) is listed on the London Stock Exchange and is a constituent of the FTSE 100 index.

 

www.intertek.com 

 

This Interim Management Statement is prepared for and addressed only to the Company's shareholders as a whole and to no other person. The Company, its directors, employees, agents or advisers do not accept or assume responsibility to any other person to whom this Interim Management Statement is shown or into whose hands it may come and any such responsibility or liability is expressly disclaimed. Statements contained in this Interim Management Statement are based on the knowledge and information available to the Company's Directors at the date it was prepared and therefore the facts stated and views expressed may change after that date. By their nature, the statements concerning the risks and uncertainties facing the Company in this Interim Management Statement involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. To the extent that this Interim Management Statement contains any statement dealing with any time after the date of its preparation such statement is merely predictive and speculative as it relates to events and circumstances which are yet to occur. The Company undertakes no obligation to update these forward-looking statements.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRGDULDBBGBI
Date   Source Headline
22nd Mar 20249:00 amRNSAnnual Financial Report
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
13th Mar 20241:00 pmRNSDirector/PDMR Shareholding
5th Mar 20247:00 amRNSFinal Results
4th Mar 20247:00 amRNSAcquisition
1st Mar 20241:00 pmRNSDirectorate Change
28th Feb 20241:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSTrading Statement
22nd Nov 20231:00 pmRNSBlock listing Interim Review
14th Sep 20231:00 pmRNSDirector Declaration
24th Aug 20237:00 amRNSAcquisition
28th Jul 20237:00 amRNSHalf-year Report
12th Jul 202310:00 amRNSDirectorate Change
7th Jun 20231:00 pmRNSDirector/PDMR Shareholding
31st May 20231:00 pmRNSDirector/PDMR Shareholding
30th May 20233:00 pmRNSHolding(s) in Company
30th May 20231:00 pmRNSBlock listing Interim Review
24th May 202311:00 amRNSResult of AGM
24th May 20237:00 amRNSTrading Statement
3rd May 20237:00 amRNSCapital Markets Event
27th Apr 20234:00 pmRNSDirector Declaration
26th Apr 20234:30 pmRNSDirector Declaration
20th Apr 20234:00 pmRNSDirector Declaration
3rd Apr 20237:00 amRNSAcquisition
24th Mar 20239:00 amRNSNotice of 2023 AGM
21st Mar 20239:00 amRNSAnnual Financial Report
20th Mar 20237:00 amRNSDirectorate Change
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSFinal Results
23rd Dec 202210:00 amRNSDirectorate Change
13th Dec 202211:00 amRNSDirector Declaration
12th Dec 20221:00 pmRNSDirector Declaration
24th Nov 20227:00 amRNSTrading Statement
21st Nov 20221:00 pmRNSBlock listing Interim Review
2nd Aug 20229:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:01 amRNSAcquisition
29th Jul 20227:00 amRNSHalf-year Report
21st Jun 20221:00 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSDirectorate Change
25th May 202211:00 amRNSResult of AGM
25th May 20227:00 amRNSTrading Statement
23rd May 20221:00 pmRNSBlock listing Interim Review
4th Apr 20223:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
18th Mar 20229:00 amRNSAnnual Financial Report
14th Mar 20221:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.